Type and screen policy in the blood bank: Is AHG cross-match still required? A study at a multispecialty corporate hospital in India
- PMID: 21897595
- PMCID: PMC3159246
- DOI: 10.4103/0973-6247.83242
Type and screen policy in the blood bank: Is AHG cross-match still required? A study at a multispecialty corporate hospital in India
Abstract
Background: Antibodies against only about 25-28 blood group antigens are known to cause hemolytic reactions (HTRs), and red cell antibody screening should detect such clinically significant antibodies. An extension of the antibody screening test is the 'type and screen' done to detect clinically significant antibodies, omiting the anti-human globulin (AHG) cross-match.
Aim: The aim of this study was to find out if the type and screen procedure is a safe method for pre-transfusion testing when compared to the AHG cross-match currently in use in India.
Materials and methods: We evaluated data from 45373 patients for whom a total of 61668 units of packed red blood cells (PRBC) were cross-matched in the AHG phase using DiaMed(®) ID cards. An antibody screen was carried out in all the patients using the DiaMed(®) ID-DiaCell I+II+III. The AHG cross-match was also carried out for all recipients, irrespective of the result of the antibody screen. The results were compared to see if there were any cases where the antibody screening was negative but the AHG cross-match showed incompatibility.
Results: Not a single case was found where the antibody screen was negative and AHG cross-match showed incompatibility. In 68 cases the antibody screening was positive. Out of the 68 cases, AHG cross-match was incompatible with at least one unit of PRBC in 41 cases.
Conclusion: The screening cell panel adequately detected the clinically significant antibodies in the Indian population in our study. The type and screen policy can be safe, efficient, cost-effective, and beneficial to the transfusion service in India.
Keywords: Anti-human globulin cross-match; alloantibodies; type and screen.
Conflict of interest statement
Similar articles
-
First Indian study to establish safety of immediate-spin crossmatch for red blood cell transfusion in antibody screen-negative recipients.Asian J Transfus Sci. 2017 Jan-Jun;11(1):40-44. doi: 10.4103/0973-6247.200774. Asian J Transfus Sci. 2017. PMID: 28316439 Free PMC article.
-
Outcome of type and screen versus crossmatch in cardiovascular surgery patients: A comparative study.Asian J Transfus Sci. 2022 Jan-Jun;16(1):1-6. doi: 10.4103/ajts.AJTS_21_19. Epub 2022 May 26. Asian J Transfus Sci. 2022. PMID: 36199399 Free PMC article.
-
Type and screen policy: is there any compromise on blood safety?Transfus Apher Sci. 2014 Apr;50(2):271-3. doi: 10.1016/j.transci.2014.01.003. Epub 2014 Jan 10. Transfus Apher Sci. 2014. PMID: 24472664
-
A multicenter prospective observational study on the use of type and screen method versus conventional type and crossmatch policy for pre-transfusion testing in the Indian population.Immunohematology. 2022 Sep 22;38(3):100-105. doi: 10.21307/immunohematology-2022-050. Print 2022 Sep 1. Immunohematology. 2022. PMID: 36190198
-
Laboratory medicine parameter. Utilizing monospecific antihuman globulin to test blood-group compatibility.Am J Clin Pathol. 1995 Aug;104(2):122-5. doi: 10.1093/ajcp/104.2.122. Am J Clin Pathol. 1995. PMID: 7639184 Review.
Cited by
-
Is It Time to Switch from Conventional Coombs Crossmatching to the Type and Screen Protocol?Malays J Med Sci. 2023 Apr;30(2):124-130. doi: 10.21315/mjms2023.30.2.11. Epub 2023 Apr 18. Malays J Med Sci. 2023. PMID: 37102041 Free PMC article.
-
First Indian study to establish safety of immediate-spin crossmatch for red blood cell transfusion in antibody screen-negative recipients.Asian J Transfus Sci. 2017 Jan-Jun;11(1):40-44. doi: 10.4103/0973-6247.200774. Asian J Transfus Sci. 2017. PMID: 28316439 Free PMC article.
-
The Distribution Patterns of Rhesus (Rh) Antigens.Cureus. 2024 Jun 16;16(6):e62476. doi: 10.7759/cureus.62476. eCollection 2024 Jun. Cureus. 2024. PMID: 39015862 Free PMC article.
-
Real eyes realizes real lies: A case report and review of nuisance antibodies in immunohematology.Asian J Transfus Sci. 2018 Jul-Dec;12(2):169-172. doi: 10.4103/ajts.AJTS_100_17. Asian J Transfus Sci. 2018. PMID: 30692805 Free PMC article.
-
Advantages of type and screen policy: Perspective from a developing country!Asian J Transfus Sci. 2018 Jan-Jun;12(1):42-45. doi: 10.4103/ajts.AJTS_31_17. Asian J Transfus Sci. 2018. PMID: 29563674 Free PMC article.
References
-
- [cited in 2010]. Available from: htt p://en.wikipedia.org/wiki/Karl_Landsteiner .
-
- [cited in 2010]. Available from: http://www.pbs.org/wnet/redgold/history/timeline4.html .
-
- [cited in 2010]. Available from: http://ibgrl.blood.co.uk/ISBT%20Pages/ISBT%20Terminology%20Pages/Termino... .
-
- Oberman HA, editor. 8th ed. Washington, DC: American Association of Blood Banks; 1976. Standards for Blood Banks and Transfusion Services.
-
- Masouredis SP. Pre-transfusion tests and compatibility: Questions of safety and efficacy. Blood. 1982;59:873–5. - PubMed